Adcock Ingram Holdings | AIP - Kapitał Własny I Rezerwy



Kapitał Własny I Rezerwy Zmiana Data
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Aspen Pharmacare ZAR 81.09B 3.81B 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Life Healthcare ZAR 11.38B 2.63B 2025-12
Moderna USD 8.65B 680M 2025-12
Netcare ZAR 10.23B 113M 2025-12
Organon & Co USD 906M 173M 2025-09
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12